Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Tilnefningarnefnd óskar eftir framboðum í stjórn
-
(Selskabsmeddelelse 3/2026) Syd Fund Management A/S har afdækket en fejl ved beregningen af indre værdi, som har medført afvigelser i emissions- og indløsningspriser. Fejlen har medført afvigelser,...
-
Iceland Seafood International hf. óskar að leiðrétta fyrri tilkynningu varðandi birtingardag ársfjórðungs- og árshlutauppgjörs fyrir árið 2025.Félagið mun birta samstæðureikning fyrir árið 2025 eftir...
-
Iceland Seafood International hf. wishes to correct an earlier communication regarding the publication date of its Q4 and full-year 2025 results.The company will publish its consolidated financial...
-
Hexagon Purus ASA's fourth quarter results 2025 will be released on 10 February 2026, 07:00 CET. Morten Holum (CEO) and Salman Alam (CFO) will present the results at 08:30 CET and the presentation...
-
ORION OYJ PÖRSSITIEDOTE – MUUT PÖRSSIN SÄÄNTÖJEN NOJALLA JULKISTETTAVAT TIEDOT 3.2.2026 KLO 9.00 62 752 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi Orion...
-
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 3 FEBRUARY 2026 at 9.00 EET 62,752 Orion Corporation A shares converted into B...
-
In January 2026, AS Tallink Grupp transported 337,926 passengers, which is a 12.6% increase compared to January 2025. The number of cargo units increased by 18.0% to 22,411 units and the number of...
-
Oslo, Norge – 3. februar 2026 – Zelluna (OSE: ZLNA), et selskap som utvikler allogene "off-the-shelf" T-cellereseptor-baserte Natural Killer (TCR-NK) celleterapier for behandling av kreft, kunngjorde...
-
Oslo, Norway, 03 February 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers,...